Genetic Testing
Ayushman India Laboratories offers genetic testing of more than 7,500 genes, specifically designed to confirm or exclude a diagnosis of almost any known genetic disorder. Ayushman India Laboratories structure with the best medical laboratories in the world which has been recognized by CAP, CLIA and ISO 15189 certifications and academic centres worldwide to bring to you the most advanced medical tests available.
NGS Services
Free Pre-and Post-test Genetic Counseling
Genetic carrier screening, prenatal screening for aneuploidy and prenatal diagnostic testing have expanded dramatically over the past two decades. Driven in part by powerful market forces, new complex testing modalities have become available after limited clinical research. The responsibility for offering these tests lies primarily on the obstetrical care provider and has become more burdensome as the number of testing options expands. Genetic testing in pregnancy is optional, and decisions about undergoing tests, as well as follow-up testing, should be informed and based on individual patients’ values and needs. Careful pre-and post-test counseling is central to supporting informed decision-making.
Whole Exome Sequencing
WES is conventionally recommended when patients present complex, heterogeneous phenotypes that are suggestive of multiple conditions or are otherwise unclear or atypical. WES may also be recommended when a prior genetic test was unsuccessful. The latest clinical evidence also supports WES as a first-line test when a patient’s symptoms or family history suggests a genetic cause of the diseases. This is especially true for neurodevelopmental disorders, including intellectual disability, global developmental delay, and autism spectrum disorder due to the high diagnostic yield. The test results from WES may also lead to more rapid diagnoses, improved prevention of symptomatic illness, more targeted treatments or even end the need for some costly or invasive procedures.
Whole Genome Sequencing
WGS is recommended especially for the diagnosis of patients with heterogeneous phenotypes, unclear or atypical clinical symptoms, or with a long list of prior differential diagnoses, or who have exhausted other genetic testing options.
Genetic Diagnosis of Hereditary Cancer
Testing for hereditary cancers can detect specific, heritable, disease-related gene mutations that may increase the risk of certain cancers allowing an in-depth cancer risk assessment for each patient. The critical goal is to detect cancer early and to give you the opportunity to maximize health outcomes for your patients. Patient-tailored screening programs, preventive measures and proactive treatment are possible for patients of a high-risk group. Early diagnosis can mean a better overall prognosis through a choice of surgical and non-surgical treatment options.
Breast and ovarian cancer (BRCA1 & BRCA2)
Breast cancer is one of the most common cancers in the world affecting ~12.5% of women during their lifetime. 5–10% of these patients have a hereditary form. Mutations in the BRCA1 and BRCA2 genes are the most common hereditary cause. However, other genes such as ATM, BRIP1, CHEK2, PALB2, RAD51, etc. have also been associated with increased risk.
_65.jpg)
Next Generation Sequencing (NGS) Panels
NGS Panels are recommended for patients that follow any or multiple of the following criteria: Distinctive clinical features: • Family history of a particular disorder • Multiple genes are linked to condition • Genetically heterogeneous disorders • Well-defined disease-associated genes
Carrier Screening
Carrier Screening can be offered to individuals considering a pregnancy or in early pregnancy. It is appropriate for individuals or couples with the following backgrounds • No family history of genetic disease • A known family history of genetic disease • High consanguinity • Ethnicities with high incidence of genetic diseases
Male and female infertility testing
A considerable number of couples suffering from infertility spend years in search of treatment options, often with physical, emotional and economic losses. Identifying the cause of infertility facilitates a personalized and informed manner of management that can be adapted to the needs of the people seeking medical support.
Sample Collection Service (Home/ Laboratory) – FREE
All test price includes free sample collection and transport to the laboratory.
About Us
Ayushman India Laboratories providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians and patients. Ayushman India Laboratories recognizes the need for quality genomic testing services in the country and beyond. The team at Ayushman India Laboratories has the competency and ample experience in handling common and complex genomic tests. The team comprises clinical geneticists, medically trained scientists, bioinformaticians, and technologists. With our expertise, we bring in clinical interpretation of genomic test results to clinicians and the patients they care for. We believe a close interaction with referring doctors is paramount to providing better results to their patients. The team aims to enable the clinicians to deliver well-informed genetic counselling to provide appropriate and timely management to families affected with rare disorders. Our team would aid in all steps of genetic testing by the clinicians including the selection of appropriate genetic and genomic tests and an apt interpretation of test results. We believe this is our core strength when it comes to quality genomic solutions for families with rare genetic disorders and cancers.
Subscribe for newsletters
We offers genetic testing of more than 7,500 genes, specifically designed to confirm or exclude a diagnosis of almost any known genetic disorder.